The Potential of Combination Therapeutics for More Complete Repair of Volumetric Muscle Loss Injuries: The Role of Exogenous Growth Factors and/or Progenitor Cells in Implantable Skeletal Muscle Tissue Engineering Technologies

Publisher： Karger

E-ISSN： 1422-6421|202|3-4|202-213

ISSN： 1422-6405

Source： Cells Tissues Organs, Vol.202, Iss.3-4, 2016-11, pp. : 202-213

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Growth Factors for Skeletal Muscle Tissue Engineering

By  

Cells Tissues Organs, Vol. 202, Iss. 3-4, 2016-11 ,pp. : 169-179

Karger

Access to resources Recommend Favorite

Myocardial Tissue Engineering and Heart Muscle Repair

By  

Current Pharmaceutical Biotechnology, Vol. 14, Iss. 1, 2013-01 ,pp. : 4-11

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiology of Volumetric Muscle Loss Injury

By  

Cells Tissues Organs, Vol. 202, Iss. 3-4, 2016-11 ,pp. : 180-188

Karger

Access to resources Recommend Favorite

Factors That Affect Tissue-Engineered Skeletal Muscle Function and Physiology

By  

Cells Tissues Organs, Vol. 202, Iss. 3-4, 2016-11 ,pp. : 159-168

Karger

Access to resources Recommend Favorite

Muscle Injuries and Repair: What's New on the Horizon!

By  

Cells Tissues Organs, Vol. 202, Iss. 3-4, 2016-11 ,pp. : 227-236

Karger

Access to resources Recommend Favorite